首页> 美国卫生研究院文献>Oncotarget >Identification of a novel metastasis inducing lncRNA which suppresses the KAI1/CD82 metastasis suppressor gene and is upregulated in triple-negative breast cancer
【2h】

Identification of a novel metastasis inducing lncRNA which suppresses the KAI1/CD82 metastasis suppressor gene and is upregulated in triple-negative breast cancer

机译:鉴定一种新型的诱导转移的lncRNA它抑制KAI1 / CD82转移抑制基因并在三阴性乳腺癌中上调

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Inactivation of tumor/metastasis suppressor genes via epigenetic silencing is a frequent event in human cancers. KAI1/CD82 is a metastasis suppressor gene whose normal protecting activity is deficient in twelve different solid malignancies. Here we have identified and characterized a primarily nuclear non-polyadenylated, antisense (as)-lncRNA, initiating upstream of the KAI1 human metastasis suppressor gene transcription start site; and elongating in the opposite direction to KAI1 mRNA. We show that the KAI1 promoter is bi-directional giving rise to KAI1 mRNA and its as-lncRNA. Moreover, expression of this lncRNA transcript emerges to be inversely related to the KAI1 mRNA expression, and in direct relationship to the invasiveness level of human breast cancer derived cell lines. Importantly, knockdown of the KAI1 as-lncRNA in the triple-negative breast cancer cell line MDA-MB-231 have led to increased KAI1 mRNA and protein expression, manifested in stronger adhesion to fibronectin, retardation of cell migration and reduced cell invasion in vitro. Accordingly we have named this lncRNA, SKAI1BC, standing for “Suppressor of KAI1 in Breast Cancer”. These results uncover a potential way to harness tumor metastasis via targeting SKAI1BC in human breast cancer, and perhaps also in other KAI1-deficient human malignancies.
机译:通过表观遗传沉默使肿瘤/转移抑制基因失活是人类癌症中的常见事件。 KAI1 / CD82是一种转移抑制基因,其正常的保护活性在十二种不同的实体恶性肿瘤中均不足。在这里,我们确定并鉴定了主要为核的非聚腺苷酸,反义(as)-lncRNA,起始于KAI1人类转移抑制基因转录起始位点的上游。并在与KAI1 mRNA相反的方向上延伸。我们表明,KAI1启动子是双向产生的KAI1 mRNA及其as-lncRNA。而且,该lncRNA转录物的表达与KAI1 mRNA表达成反比,并且与人乳腺癌衍生细胞系的侵袭性水平直接相关。重要的是,三阴性乳腺癌细胞系MDA-MB-231中KAI1 as-lncRNA的敲低导致KAI1 mRNA和蛋白质表达增加,表现为对纤连蛋白的粘附力增强,细胞迁移阻滞和体外细胞侵袭减少。因此,我们将此lncRNA命名为SKAI1BC,代表“乳腺癌中KAI1的抑制剂”。这些结果揭示了通过靶向SKAI1BC在人类乳腺癌中以及也许在其他KAI1缺陷型人类恶性肿瘤中利用肿瘤转移的潜在方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号